CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The anTBiotic project focuses on developing new treatment options for multidrug-resistant tuberculosis (TB). It aims to validate a novel drug candidate and optimize antibiotic combinations to improve outcomes for patients with drug-resistant TB in Europe and beyond.
Tuberculosis (TB) today rivals HIV/AIDS as the leading cause of death from infectious diseases.
The number of TB patients has never been higher and the growing proportion of drug-resistant TB is threatening control strategies both in the developing and developed world, Eastern Europe being a particularly worrying point in case.
The anTBiotic consortium aims to fuel the long-term TB clinical pipeline while immediately offering new options to clinicians when confronted with multidrug-resistant (MD…
GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
